WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.5 Billion CNY | 12.56% |
| 2022 | 5.06 Billion CNY | 39.93% |
| 2021 | 3.62 Billion CNY | 104.51% |
| 2020 | 1.77 Billion CNY | 55.19% |
| 2019 | 1.14 Billion CNY | 71.91% |
| 2018 | 663.9 Million CNY | 33.27% |
| 2017 | 498.16 Million CNY | 53.25% |
| 2016 | 319.08 Million CNY | 160.18% |
| 2015 | 112.31 Million CNY | 33.09% |
| 2014 | 82.37 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.47 Billion CNY | 0.0% |
| 2023 Q4 | 2.26 Billion CNY | 0.0% |
| 2023 FY | - CNY | 12.56% |
| 2023 Q2 | 2.66 Billion CNY | 0.0% |
| 2022 FY | - CNY | 39.93% |
| 2022 Q2 | 2.9 Billion CNY | 0.0% |
| 2022 Q4 | 2.16 Billion CNY | 0.0% |
| 2021 Q4 | 1.69 Billion CNY | 0.0% |
| 2021 Q2 | 1.92 Billion CNY | 0.0% |
| 2021 FY | - CNY | 104.51% |
| 2020 Q2 | 540.27 Million CNY | 0.0% |
| 2020 FY | - CNY | 55.19% |
| 2020 Q4 | 1.23 Billion CNY | 0.0% |
| 2019 FY | - CNY | 71.91% |
| 2019 Q4 | 616.69 Million CNY | 0.0% |
| 2019 Q2 | 524.63 Million CNY | 0.0% |
| 2018 FY | - CNY | 33.27% |
| 2018 Q4 | 350.53 Million CNY | 0.0% |
| 2018 Q2 | 313.37 Million CNY | 0.0% |
| 2017 FY | - CNY | 53.25% |
| 2017 Q2 | 205.81 Million CNY | 0.0% |
| 2017 Q4 | 292.35 Million CNY | 0.0% |
| 2016 Q2 | 151.09 Million CNY | 0.0% |
| 2016 Q4 | 167.98 Million CNY | 0.0% |
| 2016 FY | - CNY | 160.18% |
| 2015 Q4 | 31.23 Million CNY | 0.0% |
| 2015 FY | - CNY | 33.09% |
| 2015 Q1 | 31.23 Million CNY | 33.09% |
| 2015 Q2 | 31.23 Million CNY | 0.0% |
| 2015 Q3 | 31.23 Million CNY | 0.0% |
| 2014 Q3 | 23.46 Million CNY | 0.0% |
| 2014 Q1 | 23.46 Million CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | 23.46 Million CNY | 0.0% |
| 2014 Q2 | 23.46 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 7844.9% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 92893.919% |
| SQZ Biotechnologies Company | -64.14 Million USD | 8677.457% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 31773.385% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | -5750.464% |
| Mesoblast Limited | -62.38 Million USD | 8918.223% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 358270.019% |
| Genus plc | 73.7 Million USD | -7364.948% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 83313.384% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 155207.7% |
| Marizyme, Inc. | -34.28 Million USD | 16148.515% |
| ContraFect Corporation | -64.99 Million USD | 8564.233% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 62818.502% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 121651.701% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 392569.368% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 208145.951% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 236850.996% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 1062103.567% |
| Accustem Sciences Inc. | -3.74 Million USD | 146951.353% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 11507.857% |
| EV Biologics, Inc. | -1.26 Million USD | 434282.627% |
| Q BioMed Inc. | -617.62 Thousand USD | 890873.572% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | -153922.032% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 870058.065% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 240927.03% |
| Biomind Labs Inc. | -1.03 Million USD | 531893.757% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 9.87 Million USD | -55601.802% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 76925.244% |
| Skye Bioscience, Inc. | -13.54 Million USD | 40710.051% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 369981.848% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 22006768.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 141737.841% |
| IMV Inc. | -35.52 Million USD | 15587.447% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 34767.663% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 219994.107% |
| GB Sciences, Inc. | -1.41 Million USD | 387572.718% |
| Alpha Cognition Inc. | -9.7 Million USD | 56785.485% |
| HST Global, Inc. | -5303.00 USD | 103746413.408% |
| CSL Limited | 4.78 Billion USD | -14.881% |
| Halberd Corporation | -74.27 Thousand USD | 7406859.649% |
| Enzolytics Inc. | -2.12 Million USD | 259364.459% |
| Resverlogix Corp. | -11.74 Million USD | 46954.599% |
| Affymax, Inc. | -14.29 Million USD | 38586.655% |
| SYBLEU INC | -141.57 Thousand USD | 3886253.944% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 179716.006% |
| argenx SE | -216.02 Million USD | 2646.796% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 10041.754% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | -451967.954% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 367145.499% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | -1452124.926% |
| AVAX Technologies, Inc. | -6.11 Million USD | 90104.716% |
| Zenith Capital Corp. | -8.6 Million USD | 64028.271% |
| Genscript Biotech Corporation | -248.71 Million USD | 2311.996% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 31580761.271% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 224982.677% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 3125614.559% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 13980.179% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 190316.006% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 525915.149% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | -81821241.463% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 314481.151% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 286509.261% |
| BioStem Technologies, Inc. | -7.55 Million USD | 72934.598% |
| ONE Bio Corp. | 13.61 Million USD | -40314.671% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 3038217.932% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 267560.719% |
| Agentix Corp. | -1.37 Million USD | 401167.464% |
| LadRx Corporation | 412.28 Thousand USD | -1334339.451% |
| Cell Source, Inc. | -4.27 Million USD | 128868.485% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 1498289.646% |
| Regen BioPharma, Inc. | 1.46 Million USD | -375195.507% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 587289.591% |
| NovAccess Global Inc. | -1.03 Million USD | 531766.307% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | -62039.041% |
| Itoco Inc. | -1.86 Million USD | 294464.993% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 1449356.362% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 493080.914% |
| Kadimastem Ltd | -2.62 Million USD | 209736.749% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 2300608.886% |
| CytoDyn Inc. | -18.02 Million USD | 30615.653% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 6961679.926% |
| Mobile Lads Corp. | -2.24 Million USD | 245583.118% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | 44988790.817% |
| Qrons Inc. | -40.08 Thousand USD | 13726471.598% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 1132880.772% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | -1043002.536% |
| Rebus Holdings, Inc. | -951 Thousand USD | 578613.88% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 518142.862% |
| International Stem Cell Corporation | 202 Thousand USD | -2723497.525% |
| Bioxytran, Inc. | -3.82 Million USD | 144117.154% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 10451595.061% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 223569.495% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 15438.222% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -45 Thousand USD | 12226026.667% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 201037.436% |
| Neutra Corp. | -181.24 Thousand USD | 3035552.725% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 27391.369% |
| PureTech Health plc | -11.62 Million USD | 47418.027% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 27393.24% |
| IXICO plc | -707 Thousand USD | 778270.721% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 71689.681% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 11479.777% |
| CSL Limited | 4.73 Billion USD | -16.241% |
| Cellectis S.A. | -92.63 Million USD | 6039.016% |